Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.56 |
| ▸ | CA1 known ✓ | P00915 | 2/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 2/20 | 0.40 |
| ▸ | MMP13 | P45452 | 2/20 | 0.40 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30424973 | 1.00 | CA2 (0.56) | CA2CA1GPR84NFKB1CYP3A4 | |
| SCHEMBL3932122 | 1.00 | CA2 (0.56) | CA2CA1GPR84NFKB1CYP3A4 | |
| SCHEMBL26969246 | 1.00 | CA2 (0.56) | CA2CA1GPR84NFKB1CYP3A4 | |
| SCHEMBL247523 | 1.00 | CA2 (0.56) | CA2CA1GPR84NFKB1CYP3A4 | |
| SCHEMBL2123672 | 1.00 | CA2 (0.56) | CA2CA1GPR84NFKB1CYP3A4 | |
| SCHEMBL66700 | 1.00 | CA2 (0.56) | CA2CA1GPR84NFKB1CYP3A4 | |
| SCHEMBL11699305 | 1.00 | CA2 (0.56) | CA2CA1GPR84NFKB1CYP3A4 | |
| Potassium Ion SCHEMBL1133718 | 0.96 | CA2 (0.52) | CA2CA1GPR84NFKB1CYP3A4 | |
| Potassium Ion SCHEMBL1133667 | 0.96 | CA2 (0.52) | CA2CA1GPR84NFKB1CYP3A4 | |
| SCHEMBL5167672 | 0.89 | ZDHHC7 (0.47) | CA2CA1GPR84NFKB1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108727233-B | Dry forming process and device for improving low-temperature solubility of alpha-sodium methyl sulfopalmitate | 赞宇科技集团股份有限公司 | 2024-02-27 | — | — | CN | claimed |
| US-10758468-B2 | Solubilizer for cosmetic preparations | SYMRISE AG (DE) | 2020-09-01 | — | — | US | claimed |
| EP-0765306-B1 | ALKYL SULFOACETATE COMPOSITIONS AND METHODS FOR PREPARING SAME | STEPAN CO (US) | 1999-10-20 | — | — | EP | claimed |
| EP-0765306-A1 | ALKYL SULFOACETATE COMPOSITIONS AND METHODS FOR PREPARING SAME | STEPAN COMPANY (US) | 1997-04-02 | — | — | EP | claimed |
| WO-1995034532-A1 | ALKYL SULFOACETATE COMPOSITIONS AND METHODS FOR PREPARING SAME | STEPAN COMPANY (US) | 1995-12-21 | — | — | WO | claimed |
| EP-4620453-A1 | AQUEOUS DISPERSION OF SURFACE-HYDROPHOBIZED INORGANIC POWDER AND COSMETIC PREPARATION CONTAINING SAME | Nikko Chemicals Co., Ltd. (JP) | 2025-09-24 | — | — | EP | disclosed |
| CN-119997951-A | Method for preventing, alleviating and/or treating PTGS 2-induced skin disorders and related dysfunctions | 西姆莱斯股份公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-114728092-B | Edge block with improved odor performance | 西姆莱斯股份公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-118922168-A | Sun cream additive | 西姆莱斯股份公司 | 2024-11-08 | — | — | CN | disclosed |
| CN-118891030-A | Hair care compositions | 西姆莱斯股份公司 | 2024-11-01 | — | — | CN | disclosed |
| CN-118829416-A | Composition (III) | 西姆莱斯股份公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-118159632-A | Perfume and perfume mixture | 西姆莱斯股份公司 | 2024-06-07 | — | — | CN | disclosed |
| US-8834857-B1 | Deodorizing and skin cleaning | NEVADA NATURALS INC. (US) | 2014-09-16 | — | — | US | disclosed |
| EP-0631611-B1 | NEUTRAL pH CLEANSING BAR | PROCTER & GAMBLE (US) | 2000-02-02 | — | — | EP | disclosed |
| EP-0631614-B1 | SKIN pH CLEANSING BAR | PROCTER & GAMBLE (US) | 1999-06-09 | — | — | EP | disclosed |
| EP-0559837-B1 | SHAPED SOLID MADE WITH A RIGID, INTERLOCKING MESH OF NEUTRALIZED CARBOXYLIC ACID | PROCTER & GAMBLE (US) | 1995-10-25 | — | — | EP | disclosed |
| EP-0631611-A1 | NEUTRAL pH CLEANSING BAR | THE PROCTER & GAMBLE COMPANY (US) | 1995-01-04 | — | — | EP | disclosed |
| EP-0631614-A1 | SKIN pH CLEANSING BAR | THE PROCTER & GAMBLE COMPANY (US) | 1995-01-04 | — | — | EP | disclosed |
| WO-1993019154-A1 | NEUTRAL pH CLEANSING BAR | THE PROCTER & GAMBLE COMPANY (US) | 1993-09-30 | — | — | WO | disclosed |
| WO-1993019159-A1 | SKIN PH CLEANSING BAR | THE PROCTER & GAMBLE COMPANY (US) | 1993-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10758468-B2 | Solubilizer for cosmetic preparations | SRPK3, SRPK1, SYMPK | CA2 613/4885CA1 2900/4885GPR84 3040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.